Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Simon

Showing results (801-810 of 949) with videos related to

Pageof 95
Sort By:
Neurology|May 10, 2006
MRI T2 lesion burden in multiple sclerosis: a plateauing relationship with clinical disabilityD K B Li, U Held, J Petkau, et al.
Annals of the American Thoracic Society|August 16, 2019
Measures of Cystic Fibrosis Airway Microbiota during Periods of Clinical StabilityLindsay J Caverly, Junnan Lu, Lisa A Carmody, et al.
Antimicrobial Agents and Chemotherapy|November 16, 2023
Optimizing dosing of the cycloserine pro-drug terizidone in children with rifampicin-resistant tuberculosisLouvina E van der Laan, Anthony J Garcia-Prats, Helen McIlleron, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 10, 2020
Rapid reductions and millennial-scale variability in Nordic Seas sea ice cover during abrupt glacial climate changesHenrik Sadatzki, Niccolò Maffezzoli, Trond M Dokken, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 1, 1995
A phase III trial of intramuscular recombinant interferon beta as treatment for exacerbating-remitting multiple sclerosis: design and conduct of study and baseline characteristics of patients. Multiple Sclerosis Collaborative Research Group (MSCRG)L D Jacobs, D L Cookfair, R A Rudick, et al.
Antimicrobial Agents and Chemotherapy|November 15, 2017
Levofloxacin Population Pharmacokinetics in South African Children Treated for Multidrug-Resistant TuberculosisPaolo Denti, Anthony J Garcia-Prats, Heather R Draper, et al.
Antimicrobial Agents and Chemotherapy|December 25, 2019
Population Pharmacokinetics and Dosing of Ethionamide in Children with TuberculosisHenrik Bjugård Nyberg, Heather R Draper, Anthony J Garcia-Prats, et al.
Antimicrobial Agents and Chemotherapy|November 15, 2017
Pharmacokinetics and Drug-Drug Interactions of Lopinavir-Ritonavir Administered with First- and Second-Line Antituberculosis Drugs in HIV-Infected Children Treated for Multidrug-Resistant TuberculosisLouvina E van der Laan, Anthony J Garcia-Prats, H Simon Schaaf, et al.
Leukemia & Lymphoma|November 8, 2001
A multicentric study of 41 cases of B-prolymphocytic leukemia: two evolutive formsC Hercher, M Robain, F Davi, et al.
Burns : Journal of the International Society for Burn Injuries|June 17, 2026
How the world manages acute burns: Insights from an international survey of 106 burn units across 50 countriesRoos F C Salemans, Myrthe H Simon, Margriet E van Baar, et al.
Pageof 95

Showing results (801-810 of 949) with videos related to

Sort By:
Pageof 95
Neurology|May 10, 2006
MRI T2 lesion burden in multiple sclerosis: a plateauing relationship with clinical disabilityD K B Li, U Held, J Petkau, et al.
Annals of the American Thoracic Society|August 16, 2019
Measures of Cystic Fibrosis Airway Microbiota during Periods of Clinical StabilityLindsay J Caverly, Junnan Lu, Lisa A Carmody, et al.
Antimicrobial Agents and Chemotherapy|November 16, 2023
Optimizing dosing of the cycloserine pro-drug terizidone in children with rifampicin-resistant tuberculosisLouvina E van der Laan, Anthony J Garcia-Prats, Helen McIlleron, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 10, 2020
Rapid reductions and millennial-scale variability in Nordic Seas sea ice cover during abrupt glacial climate changesHenrik Sadatzki, Niccolò Maffezzoli, Trond M Dokken, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 1, 1995
A phase III trial of intramuscular recombinant interferon beta as treatment for exacerbating-remitting multiple sclerosis: design and conduct of study and baseline characteristics of patients. Multiple Sclerosis Collaborative Research Group (MSCRG)L D Jacobs, D L Cookfair, R A Rudick, et al.
Antimicrobial Agents and Chemotherapy|November 15, 2017
Levofloxacin Population Pharmacokinetics in South African Children Treated for Multidrug-Resistant TuberculosisPaolo Denti, Anthony J Garcia-Prats, Heather R Draper, et al.
Antimicrobial Agents and Chemotherapy|December 25, 2019
Population Pharmacokinetics and Dosing of Ethionamide in Children with TuberculosisHenrik Bjugård Nyberg, Heather R Draper, Anthony J Garcia-Prats, et al.
Antimicrobial Agents and Chemotherapy|November 15, 2017
Pharmacokinetics and Drug-Drug Interactions of Lopinavir-Ritonavir Administered with First- and Second-Line Antituberculosis Drugs in HIV-Infected Children Treated for Multidrug-Resistant TuberculosisLouvina E van der Laan, Anthony J Garcia-Prats, H Simon Schaaf, et al.
Leukemia & Lymphoma|November 8, 2001
A multicentric study of 41 cases of B-prolymphocytic leukemia: two evolutive formsC Hercher, M Robain, F Davi, et al.
Burns : Journal of the International Society for Burn Injuries|June 17, 2026
How the world manages acute burns: Insights from an international survey of 106 burn units across 50 countriesRoos F C Salemans, Myrthe H Simon, Margriet E van Baar, et al.
Pageof 95